Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by GoldenDilemmaon Sep 15, 2016 3:51pm
85 Views
Post# 25242080

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Pre-bids $8.75.......

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Pre-bids $8.75.......
Bigboyone wrote: Ok, I am following you now, Keep shorting unitl the price is favorable (lower) to cover,..Dangerous, but you really think that many traders have the $ and the cajones to do that? 


On near 10 million volume you can bet it's not your neighbour and their family causing the volatility with ARLZ :P

They are playing the odds, though.

Here's what they can consider:

a) the pre-approval run up 

b) the big short attack yesterday on anticipation of CRL

c) drug approval happens, intraday high of $6.70 was not retested immediately showing out of the gates this puppy does not have much strength on the demand side to take us past that simply cuz the demand was priced in, or they are holding

d) continue to add to net short position, covering on ask, given that the approval DID happen and there isn't much incentive to hold onto this short

e) likely the heavy shorts are also on the options side of things - take the price to where it needs to be so you at least win on the options side of things if we can stay below $6 or above $5 depending what you bought/sold. 

1 min chart via stochastics (slow/fast) show how much emphasis is put on keeping the price low via how quickly things become overbought when the price is only moving 2 - 5 cents. That is not indicative of a healthy upward trend or strong momentum causing the price to go up if the range at which it is showing overbought is so narrow and tight. 
<< Previous
Bullboard Posts
Next >>